Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
about
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentOverexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte contentThe role of tumour-derived iNOS in tumour progression and angiogenesisEvaluation of wedged arterial injection as a new technique for delivery of experimental therapeutic substances into the porcine pancreas.Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverIdentification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a reviewThe role of nitric oxide in mediating tumour blood flow.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.Gasotransmitters in cancer: from pathophysiology to experimental therapy.NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.Targeting eNOS in pancreatic cancer.The transfusion problem: role of aberrant S-nitrosylation.Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.Evidences supporting the vascular etiology of post-double balloon enteroscopy pancreatitis: Study in porcine model.Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
P2860
Q24657761-6D9AAB51-AE48-4080-8E60-B529D061F71EQ30479724-9295F03F-12E4-461E-B960-188C7DF5CA2FQ33765559-1CE2FBB2-6A6E-4097-A80E-1158BB554CBBQ34050427-A354447C-2C11-4B08-B685-781AB3BB842FQ35346619-6FF6B40F-F2F1-4A13-9871-C8686A1976E9Q35418987-BBA4AED3-5AD2-480B-95CF-5F911DFE7633Q35456945-DF1A7FF6-664E-445F-9456-ADF35E722744Q36061770-837EB80A-4CF9-4570-AF91-D27E17B0808CQ36596676-F3478880-405F-4553-AAB3-E44AA8454DA7Q37038711-E536C48C-9BF6-4E37-92B7-049B870AD6CCQ37656625-E29853A7-4F3C-43D9-B890-DC21820057CBQ38832619-9DD12579-EE2D-446F-B667-2118BBEB7B58Q39324277-F4DA66E1-942D-49AE-A723-DA6A045B9508Q41575009-66940F70-E918-4061-9F16-49CC176D58BBQ41817769-CDE208AF-E5C8-45E0-AFD9-E89893640221Q41954266-744AAA6E-B0E6-4DD0-8CBD-9EED6AFF9AB2Q42037739-558B2958-A2AE-4D6C-A345-168694486A90Q46817255-506ADBE9-0A70-4EDA-AC29-ED36C212604F
P2860
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@ast
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@en
type
label
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@ast
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@en
prefLabel
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@ast
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@en
P2093
P1476
Roles of nitric oxide synthase ...... vo model of pancreatic cancer.
@en
P2093
Anthony Yang
Daniel J Hicklin
E Ramsay Camp
Lee M Ellis
Ray Somcio
Wenbiao Liu
P304
P356
10.1158/1078-0432.CCR-05-2257
P407
P577
2006-04-01T00:00:00Z